SCHEMBL28048189

SCHEMBL28048189

CC(=O)Oc1ncc(N)cn1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 1/20 0.36
CTSL P07711 1/20 0.35
CTSB P07858 1/20 0.35
LMNA P02545 3/20 0.34
ALDH1A1 P00352 3/20 0.34
HPGD P15428 2/20 0.34
F2 P00734 1/20 0.34
GLA P06280 1/20 0.34
TSHR P16473 3/20 0.32
GABRP O00591 1/20 0.32
GABRD O14764 1/20 0.32
GABRA1 P14867 1/20 0.32
GABRB1 P18505 1/20 0.32
GABRG2 P18507 1/20 0.32
GABRB3 P28472 1/20 0.32
GABRA5 P31644 1/20 0.32
GABRA3 P34903 1/20 0.32
GABRA2 P47869 1/20 0.32
GABRB2 P47870 1/20 0.32
GABRA4 P48169 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28808109 0.80 CYP3A4 (0.39) LMNAALDH1A1HPGDF2GLA
SCHEMBL27080876 0.78 ALDH1A1 (0.36) LMNAALDH1A1HPGDF2GLA
SCHEMBL8439769 0.78 LMNA (0.34) LMNAALDH1A1HPGDF2GLA
Methylamine SCHEMBL536416 0.76 KDM4E (0.41) LMNAALDH1A1HPGDF2GLA
SCHEMBL1291212 0.75 KDM4E (0.43) LMNAALDH1A1HPGDF2GLA
SCHEMBL22557537 0.74 KDM4E (0.44) CYP19A1CTSLCTSBLMNAALDH1A1
SCHEMBL28048187 0.74 POLB (0.40) LMNAALDH1A1POLBMAPTPKM
SCHEMBL6677424 0.73 LMNA (0.37) LMNAALDH1A1HPGDF2GLA
SCHEMBL12471969 0.71 LMNA (0.35) LMNAALDH1A1HPGDF2GLA
SCHEMBL25183271 0.70 NFKB1 (0.35) TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105164121-A Perfluorinated cyclopropyl-fused 1, 3-oxazin-2-amine compounds as beta-secretase inhibitors and methods of use thereof AMGEN INC 2015-12-16 CN disclosed